Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21

Brain Research

Volumn 674, Issue 2, 1995, Pages 252-259

  Arendash, Gary W ^a,b   Sengstock, Gregory J ^a   Sanberg, Paul R ^b   Kem, William R ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Acetylcholine; Age associated memory impairment; Aging; Cognition enhancing; Nicotine; Nicotinic agonist; Rat

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; 3 (4 DIMETHYLAMINOBENZYLIDENE)ANABASEINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT;

AGING; ANABASINE; ANIMAL; AVOIDANCE LEARNING; BENZYLIDENE COMPOUNDS; COGNITION; LEARNING; MALE; MAZE LEARNING; MEMORY; MEMORY, SHORT-TERM; NICOTINE; NICOTINIC AGONISTS; PSYCHOTROPIC DRUGS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; STIMULATION, CHEMICAL; SUPPORT, NON-U.S. GOV'T;

EID: 0028934741     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(94)01449-R     Document Type: Article

References (49)

1. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease
2. The effect of pre- and post-trial application of nicotine on the 12 problems of the Hebb-Williams test in the rat
3. Nicotine and coronary heart disease
4. Stability of neuronal number in the human nucleus basalis of Meynert with age
5. Neuron numbers and dendritic extent in normal aging and Alzheimer's Disease
6. The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system
7. Effects of nicotine on spatial memory deficits in rats with septal lesions
8. Effects of lobeline, a nicotinic receptor agonist, on learning and memory
9. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities. II. In vivo characterization
10. Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats
11. Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging
12. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment
13. Spatial learning deficits in old rats: a model for memory decline in the aged
14. Age-dependent changes in retention in rats
15. Cholinergic modulation of memory in rats
16. Nicotine as a tool to characterize the role of the forebrain cholinergic projection system in cognition
17. A novel nicotinic agonist facilitates induction of long term potentiation in the rat hippocampus
18. Complex maze learning in rodents as a model of age-related memory impairment
19. Effects of subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease
20. A study of the occurrence of anabaseine in Paranemertes and other nemertines
21. Isolation and structure of a hoplonemertine toxin
22. Actions of anabaseine and DMAB-anabaseine upon neuronal α4β2 and PC12 cell nicotinic receptors
23. Nicotinic systems and cognitive function
24. Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection
25. Mecamylamine-induced deficits in eyeblink conditioning: reversed by nicotine agonists
26. Neurotoxin distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations
27. Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors
28. The effects of nicotinic agents on human cognition: possible therapeutic applications in Alzheimer's and Parkinson's diseases
29. Spatial memory and hippocampal function
30. The subunit specific effects of novel anabaseine-derived nicotinic agents
31. Behaviorism, cognitivism and the neuropsychology of memory
32. The silent epidemic: the search for treatment of age-related memory impairment
33. Effects of nicotine gum on repeated administration of the Stroop test
34. A post-mortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease
35. The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of Alzheimer type
36. Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease
37. Molecular cloning, functional properties, and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium
38. Nucleus basalis lesions in neonate rats induce a selective cortical cholinergic hypofunction and cognitive deficits during adulthood
39. Classical eyeblink conditioning in Alzheimer's disease patients
40. The effects of nucleus basalis lesions in the rat one-way passive and active avoidance, two-way avoidance, and Lashley III maze learning: an animal model for SDAT
41. Neocortical cell counts in normal human adult aging
42. Nicotine as a cognitive enhancer
43. Eyeblink conditioning discriminates Alzheimer's patients from non-demented aged
44. A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain
45. Basal forebrain cholinergic neurons in aged rat brain are more susceptible to ibotenate-induced degeneration than neurons in young adult brain
46. Long range transmission of polar effects in cholinergic 3-arylideneanabaseine conformations calculated by molecular modelling
47. Rapid forgetting in aged rats